Jason Paul Steik
CIK 2078374 · View on SEC EDGAR ↗
First SEC filing: July 31, 2025 · Latest: July 31, 2025
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 6, 2026 | PNTG | S | 1,394 | $38.52 | $53,697 | 15,106 Direct | -8.45% | Disposed | 1.6% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 11 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 31, 2025 | PNTG | Common Stock | 16,500 | Direct |
| July 31, 2025 | PNTG | Common Stock | 647 | Direct |
| July 31, 2025 | PNTG | Stock Option (right to buy)→ Common Stock | — | Direct |
| July 31, 2025 | PNTG | Stock Option (right to buy)→ Common Stock | — | Direct |
| July 31, 2025 | PNTG | Stock Option (right to buy)→ Common Stock | — | Direct |
| July 31, 2025 | PNTG | Stock Option (right to buy)→ Common Stock | — | Direct |
| July 31, 2025 | PNTG | Stock Option (right to buy)→ Common Stock | — | Direct |
| July 31, 2025 | PNTG | Stock Option (right to buy)→ Common Stock | — | Direct |
| July 31, 2025 | PNTG | Stock Option (right to buy)→ Common Stock | — | Direct |
| July 31, 2025 | PNTG | Stock Option (right to buy)→ Common Stock | — | Direct |
| July 31, 2025 | PNTG | Stock Option (right to buy)→ Common Stock | — | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
PNTG
Chief Clinical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $283,654 | $1,031,274 | — | $516,593 | — | — | $1,765 | $1,833,286 |
| 2024 | $269,344 | $472,200 | $82,000 | $185,342 | — | — | $1,708 | $1,010,594 |
| 2023 | $257,726 | $250,000 | — | $212,304 | — | — | $966 | $720,996 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.